Latest in Nordisk Shares Rise
Sort by
477 items
-
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.CNBC - 3h -
Nissan and Honda shares rise as report says automakers may call off merger talks
Honda and Nissan are considering calling off their merger talks, Japan's Asahi Shimbun reported on Wednesday citing several sources.CNBC - 12h -
Novo Nordisk sales beat estimates, but the story wasn’t Ozempic
Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.MarketWatch - 5h -
Santander profits rise at UK arm
Spanish lender says it faces competitive environment in market where future of its business remains in doubtFinancial Times - 7h -
The rise of the "Regina George" liberal
Viral TikTok influencer Suzanne Lambert has built a following by being a "mean" Democrat. Lambert joins "America Decides" to explain why she thinks it's time for a tone shift in the party.CBS News - 1d -
Novo Nordisk Foundation Will Not Fill Funding Gaps
Global health experts have questioned how philanthropies could mitigate Trump’s freeze on foreign health aid.Inc. - 1d -
Eurozone inflation rises to 2.5% in January
Price increases stay above ECB’s 2% target but policymakers are confident they will reach that threshold this yearFinancial Times - 2d -
NHL Salary Cap On The Rise
The NHL announced significant increases to the salary cap's upper and lower limits starting in 2025-26 and progressing through the 2027-28 season.Yahoo Sports - 4d -
-
Apple shares rise 3% as boost in services revenue overshadows iPhone miss
Although Apple's overall sales rose during the quarter, the company's closely watched iPhone sales actually declined slightly on a year-over-year basis.CNBC - 5d -
IBM shares rise 9% on earnings beat
In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business.CNBC - 6d -
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.CNBC - Jan. 28 -
Nvidia, Microsoft shares tumble amid rise of China-based AI DeepSeek
DeepSeek chatbot tops Apple's app-store charts.ABC News - Jan. 27 -
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.CNBC - Jan. 24 -
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - Jan. 24 -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - Jan. 24 -
Reddit shares rise 7%, hit record as Raymond James raises price target
Reddit shares closed up more than 7% to a record high Tuesday after Raymond James analysts raised their price target and reiterated their "strong buy" rating.CNBC - Jan. 21 -
Country Garden Shares Rise After Monthslong Suspension
Shares in the company, once one of China’s largest developers, rose on the resumption of trade after it pledged to reach a debt-restructuring deal with creditors.The Wall Street Journal - Jan. 21 -
The rise in NFL quarterbacks running the ball
NFL quarterbacks are running the ball more than ever. It's a game-changer for the league with some calling out safety concerns. NBC News' Steve Kornacki breaks it down for us.NBC News - Jan. 20 -
Readers Share Their Near-Death Experiences
After the death of Peter Fenwick, a neuropsychiatrist who studied near-death experiences, readers shared stories of their own.The New York Times - Jan. 17 -
Inside the rise and fall of the ABL
It lasted only 2½ seasons but remains an important chapter in professional women's hoops history.ESPN - Jan. 16 -
Shares of Cartier owner Richemont jump 16% as sales rise in December quarter
Cartier owner Richemont on Thursday reported a 10% increase in third quarter sales even as China demand weighed.CNBC - Jan. 16 -
Goldman Sachs shares rise after topping estimates on strong trading results
Goldman's fourth-quarter results will give investors a preview of what to expect this year, as investment banking and trading fees are both expected to rise.CNBC - Jan. 15 -
The Madcap Rise of Memecoin Factory Pump.Fun
Pump.Fun raked in hundreds of millions of dollars in its first year in operation. Despite some growing pains, its creators say this is just the beginning.Wired - Jan. 15 -
Is US inflation set to rise further?
Market Questions is the FT’s guide to the week aheadFinancial Times - Jan. 12 -
Vodafone Sells Remaining 3% Share in Indus Towers
The telecomms group used the $326 million raised in proceeds to repay debt and increase its stake in India’s Vodafone Idea.The Wall Street Journal - Jan. 10 -
Lloyds, Halifax and Bank of Scotland to share branches
The move is intended to make it easier for people to access banking services, but some warn it will lead to more branch closures.BBC News - Jan. 9 -
The risk of nuclear war continues to rise
As the world became more dangerous in 2024, the use of its most dangerous weapons has become more likely.The Hill - Jan. 9 -
Greggs shares drop on sales slowdown
UK bakery chain blames ‘subdued high street footfall’ for weaker earningsFinancial Times - Jan. 9 -
Trump shares inflammatory video with crude reference to Netanyahu
President-elect’s post featuring economist Jeffrey Sachs comes weeks after Israeli PM claims two had a ‘warm’ chat. Donald Trump has shared inflammatory video content calling Benjamin Netanyahu ...The Guardian - Jan. 9 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8 -
The rise and rise of Newcastle's Isak
With Alexander Isak leading the charge for a reinvigorated Newcastle United, BBC Sport looks at the rise of Tyneside's crown jewel.BBC News - Jan. 7 -
A Timeline of Justin Trudeau’s Rise and Fall
The Canadian prime minister, who said on Monday he would step down, has spent a quarter-century in the political spotlight.The New York Times - Jan. 7 -
Belichick shares on-brand reaction to Patriots firing Mayo
Former Patriots head coach Bill Belichick shared his reaction to the firing of his successor, Jerod Mayo, on Monday's "The Pat McAfee Show."Yahoo Sports - Jan. 6
